Get started
Author

Paloma Peinado

Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
2019 · Ramy R. Saleh, Paloma Peinado, et al. · Frontiers in Oncology · 70
PDF
Fatal Autoimmune Storm After a Single Cycle of Anti-PD-1 Therapy: A Case of Lethal Toxicity but Pathological Complete Response in Metastatic Lung Adenocarcinoma
2020 · Jesús Fuentes-Antrás, Paloma Peinado, et al. · Hematology/Oncology and Stem Cell Therapy · 26
Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis
2019 · Ramy R. Saleh, Jesús Fuentes Antrás, et al. · Cancer Treatment Reviews · 20
Developing and Validating Multi-Modal Models for Mortality Prediction in COVID-19 Patients: a Multi-center Retrospective Study
2022 · Joy Tzung-yu Wu, Miguel Ángel Armengol de la Hoz, et al. · Journal of Imaging Informatics in Medicine · 16
PDF
Systemic Therapeutic Options in Radioiodine-Refractory Differentiated Thyroid Cancer: Current Indications and Optimal Timing
2025 · Tamara Díaz Vico, Brezo Martínez-Amores Martínez, et al. · Cancers · 13
PDF
Neuroendocrine neoplasms in rare locations: Clinicopathological features and review of the literature
2018 · CristinaDíaz del Arco, Javier Sastre, et al. · Indian Journal of Endocrinology and Metabolism · 13
Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer
2016 · Isabel Echavarria, Mónica Granja, et al. · Breast Cancer Research and Treatment · 12
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
2025 · Gregory M. Cote, Sant P. Chawla, et al. · Future Oncology · 7
PDF
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer
2025 · Florian Castet, Carles Fabregat-Franco, et al. · Journal of Hepatology · 6
Circulating tumor DNA using a plasma-only assay predicts survival in patients with oligometastatic colorectal cancer after definitive therapy
2025 · Enrique Sanz-Garcia, Paloma Peinado, et al. · Journal of Gastrointestinal Oncology · 5
Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosis
2025 · Alberto Langtry, Raul Rabadan, et al. · Nature Communications · 4
PDF
Real-world management and outcome of patients with pancreatic adenocarcinoma. Results of the Spanish RETUD gastrointestinal registry
2025 · T. Macarulla, A. Muñoz, et al. · ESMO Real World Data and Digital Oncology · 4
PDF
Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case Report
2024 · Marisa Torres Velasco, Rafael Álvarez Gallego, et al. · Case Reports in Oncology · 4
Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026 · Laura Visa, Jordi Badia-Ramentol, et al. · Clinical Cancer Research · 2
MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry
2025 · A.J. Muñoz Martín, F. Castet, et al. · ESMO Gastrointestinal Oncology · 2
PDF
Phase 2, Multicenter, Open-label, Nonrandomized Study of Neoadjuvant Chemotherapy Liposomal Irinotecan With 5-Fluorouracil, Leucovorin, and Oxaliplatin, Followed by Chemoradiotherapy in Patients With Rectal Cancer in a Watch-and-Wait Program
2024 · César Muñoz, María-C. Riesco Martinez, et al. · American Journal of Clinical Oncology · 2
Randomized controlled, open-label, phase IIb/III study of lurbinectedin in combination with doxorubicin versus doxorubicin alone as first-line treatment in patients with metastatic leiomyosarcoma.
2024 · Gregory Michael Cote, Sant P. Chawla, et al. · Journal of Clinical Oncology · 2
PDF
932P Survival in patients with relapsed/metastatic head and neck squamous cell carcinoma (HNSCC) treated with pembrolizumab or cetuximab-based therapy: A real-worlddata study with the TriNetX platform
2023 · L. Ugidos De La Varga, N. Ruiz del Arbol, et al. · Annals of Oncology · 2
PDF
MDM2 amplification in patients with biliary tract cancer in RETUD registry.
2025 · Andrés J. Muñoz Martín, Florian Castet, et al. · Journal of Clinical Oncology · 1
126P Biliary tract cancer (BTC) characterization on a cohort of patients (pt) from the Spanish RETUD Registry
2023 · A. Lacasta, T. Macarulla, et al. · Annals of Oncology · 1
PDF
1760P COVID-19 severe pneumonia in cancer patients: Impact and predictive factors
2020 · P. Peinado, E. Sanz Garcia, et al. · Annals of Oncology · 1
PDF
1749P COVID-19 impact and predictive factors for mortality in cancer patients
2020 · E. Sanz Garcia, P. Peinado, et al. · Annals of Oncology · 1
PDF
Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer
2019 · Paloma Peinado, Carmen Ramírez, et al. · Breast Care · 1
Neuroendocrine tumors in rare locations: Description of 27 cases
2019 · Paloma Peinado, Cristina Díaz del Arco, et al. · Medicina Clínica · 1
Supplementary Figure S2 from Next-Generation Sequencing of Circulating Tumor DNA for Precision Medicine in Patients with Advanced Biliary Tract Cancers
2026 · Laura Visa, Jordi Badia-Ramentol, et al.
Works count: 45
Citation count: 216
H-index: 7
I10-index: 7
Year
Topic
Type